Cargando…
Myeloid-Specific Acly Deletion Alters Macrophage Phenotype In Vitro and In Vivo without Affecting Tumor Growth
SIMPLE SUMMARY: Tumor cells show different metabolism compared to normal tissue. For instance, they increase ATP-citrate lyase (Acly) expression for increased proliferation. Acly is therefore currently being targeted for cancer therapy. However, targeting this enzyme may have side effects on other c...
Autores principales: | de Goede, Kyra E., Verberk, Sanne G. S., Baardman, Jeroen, Harber, Karl J., van Kooyk, Yvette, de Winther, Menno P. J., Schetters, Sjoerd T. T., Van den Bossche, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235155/ https://www.ncbi.nlm.nih.gov/pubmed/34205266 http://dx.doi.org/10.3390/cancers13123054 |
Ejemplares similares
-
Myeloid ATP Citrate Lyase Regulates Macrophage Inflammatory Responses In Vitro Without Altering Inflammatory Disease Outcomes
por: Verberk, Sanne G. S., et al.
Publicado: (2021) -
Succinate Is an Inflammation-Induced Immunoregulatory Metabolite in Macrophages
por: Harber, Karl J., et al.
Publicado: (2020) -
An integrated toolbox to profile macrophage immunometabolism
por: Verberk, Sanne G.S., et al.
Publicado: (2022) -
Going -omics to identify novel therapeutic targets for cardiovascular disease
por: Harber, Karl J., et al.
Publicado: (2019) -
Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages’ transition into a pro-inflammatory state
por: Bosmans, Laura A, et al.
Publicado: (2022)